A cryptocurrency (or crypto currency) is a digital asset designed to work as a
medium of exchange that uses cryptography to secure its transactions, to control the
creation of additional units, and to verify the transfer of assets. Cryptocurrency
mainly uses decentralized control with all transactions recorded in a database called
Blockchain. The first decentralized cryptocurrency created was Bitcoin in 2009.
Since then, the crypto world has grown exponentially in the last couple years.
Massive adoption of blockchain technology cannot be evaded in the coming
years as cryptocurrency is becoming increasingly easier to access and own. There
are at least 1500 cryptocurrencies currently in the market. One of these is DNAtix Token.
DNAtix intends to create a future ecosystem for Genetics where consumers,
researchers, laboratories and clinics operate making Genetics more accessible,
transparent and anonymous.
DNAtix intends to offer cutting-edge Genetics and Blockchain services which
intends to be anonymous and encrypted and intends to include: analysis, storage
and transfer of digitized DNA sequences through a Direct-to Consumer
DNAtix intends to sell a crypto Token – DNAtix token, that intends to support
future development and use of its DNAtix genetic platform. The DNAtix platform
intends to enable users to upload partial or full genomic sequences in an easy
and anonymous manner. It intends to allow genetic tests to be performed
and intends to offer clients the opportunity to get referrals to an appropriate
solution provider for tested genetic conditions. DNAtix intends to enable its
users to take ownership of their genetic data, encouraging them to manage their
health today, moving from Reactive to Preventative medicine.
THE PROBLEM THE PLATFORM TENDS TO SOLVE
Direct-to-Consumer (D2C) genetic services hold huge promise for users with forecasted exponential growth. For many years D2C services remained in their infancy stage because of:
Worldwide health authorities have demonstrated indecision towards D2C
genetic services until now.
The number one issue in modern genetic health for undertaking Full Genome Sequencing.
It has been a very expensive service, preventing it being accessible to all.
Genetic data is highly sensitive. Distribution of genetic data over the web ensuring privacy and integrity of data in the past was very limited. This has changed due to the development of the Blockchain technology and Smart Contracts that provide both security and anonymity.
We are standing at the threshold of a major disruption in the Genetic testing space. Different health fields are coming together to collaborate and enhance each other’s activities and growth, thus making DNAtix services and the DNAtix token the right technology, at the right time and place.
DNAtix intends to be at the forefront with its technology:
The Food and Drug Administration (FDA) has recently allowed 23andMe to market 10 genetic tests direct to consumers. These tests include health related genetic tests for Parkinson, Celiac and Alzheimer’s disease (1).
This first approval will enable other companies including DNAtix, to offer genetic services directly to clients.
DNAtix is currently the only company that offers a working platform performing digital analysis, storage, and transfer of DNA sequences soon to implement encrypted block-chain technology.
*COSTS AND TIME
The costs of Full Genome Sequencing are dropping. What was once completed at a cost of $3.5 billion and required 13 years, will very soon be offered at the price of $100 and will be completed in just a few hours (2,3).
Up until now, there has been no way to provide anonymous, direct to consumer genetic services. The DNAtix token will enable, for the first time, an anonymous and secure method for analysis, transfer, storage and payment of DNA sequences.
This white paper presents our strategy for becoming the leading company in the D2C genetic services space.
DNAtix is developing the future ecosystem of genetics where consumers, researchers, laboratories and clinics meet to use and manufacture genetics in a more transparent, accessible, enforceable and secure way.
A state-of-the-art genetic platform based on the blockchain providing anonymous and encrypted genetic services, including the analysis, storage and transfer of digitized DNA sequences via a platform directly to the consumer.
DNAtix completed the first proof of concept (POC) test by transferring the complete genome sequence of a virus to the Ethereum block chain. This test is a key step and the company believes that this is the first time someone successfully transfers a DNA sequence to a blockchain.
This will be the only payment method accepted on the DNAtix platform. The total supply of these coins is fixed at 150 000 000 VND, which means that no additional token is issued. During the first year, 15% of DNAtix will be stored in the reserve account.
DNAtix is expected to launch an ICO in June 2018. During this event, 85% of the 150,000 DNAtix chips will be sold. The fundraising helmet is set at $ 30 million. Further details regarding the next ICO are not yet available on the project website.
- Token symbol: DNTX
- The sale of chips begins: June 2018
- Token price: $ 0.01
- Total Supply: 150,000,000
- Hard Cap: $ 30 million